Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01514760 · ClinicalTrials.gov registry record · NA

A Pilot and Feasibility Study of Mobile-Based Asthma Action Plans

A NA study of Asthma, sponsored by Arkansas Children's Hospital Research Institute.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT01514760: Completed NA study of Asthma, sponsored by Arkansas Children's Hospital Research Institute.

NCT01514760 is a NA study of Asthma that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 22 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01514760, a NA study of Asthma, has completed, sponsored by Arkansas Children's Hospital Research Institute.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

Investigators from University of Arkansas for Medical Sciences Department of Pediatrics and University of Arkansas for Medical Sciences Center for Distance Health will collaborate to develop a mobile-based Asthma Action Plan application to improve asthma self-management skills specifically targeting adolescents. The investigators hypothesize that an interactive, mobile-based asthma action plan will be a feasible means of reinforcing long-term asthma management guidelines as well as delivering acute management instructions to adolescents with asthma.

Primary Outcome

Median number of days per week (range 0-7) the Asthma Action Plan was utilized to record routine (daily) symptoms or peak flow measurements.

Conditions Studied

Interventions

  • OTHER Mobile-based Asthma Action Plan

Study Locations (1)

Arkansas

  • Arkansas Children's Hospital Research Institute - Little Rock

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2012-06
Est. Completion 2013-10
Phase NA

What the finished NCT01514760 record still lists

NCT01514760 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Mobile-based Asthma Action Plan is the first listed.

NCT01514760 reports a single indexed study location in Arkansas.

Frequently Asked Questions

What is clinical trial NCT01514760 about?

NCT01514760 is a clinical study titled "A Pilot and Feasibility Study of Mobile-Based Asthma Action Plans". Investigators from University of Arkansas for Medical Sciences Department of Pediatrics and University of Arkansas for Medical Sciences Center for Distance Health will collaborate to develop a mobile-based Asthma Action Plan application to improve asthma self-management skills specifically targeting...

What is the current status of trial NCT01514760?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2012-06. Estimated completion is 2013-10.

What conditions does trial NCT01514760 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT01514760?

The interventions under investigation include: Mobile-based Asthma Action Plan (OTHER).

Who is sponsoring clinical trial NCT01514760?

This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01514760 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01514760's enrollment target sits among peer trials

22 332nd of 374 higher than 39 of 374 other Asthma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01514760, the US trial registry maintained by the National Library of Medicine. NCT01514760 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.